Developments in intravesical therapy for non-muscle-invasive bladder cancer. - Wikidata - wikimedia - TriplyDB

Developments in intravesical therapy for non-muscle-invasive bladder cancer.

Developments in intravesical therapy for non-muscle-invasive bladder cancer.

http://www.wikidata.org/entity/Q37812604

about

Factors affecting valrubicin response in patients with bacillus Calmette-Guérin-refractory bladder carcinoma in situ.Hyperthermic Intravesical Chemotherapy for BCG Unresponsive Non-Muscle Invasive Bladder Cancer Patients

P2860

Q42600757-52C25F4F-4D98-41FA-9B7E-ACF690F6E895 Q58705101-7EB39BCE-DE46-4852-80D3-48F53882127B

P2860

Developments in intravesical therapy for non-muscle-invasive bladder cancer.

http://www.wikidata.org/entity/Q37812604

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Developments in intravesical therapy for non-muscle-invasive bladder cancer.

@en

Developments in intravesical therapy for non-muscle-invasive bladder cancer.

@nl

type

label

Developments in intravesical therapy for non-muscle-invasive bladder cancer.

@en

Developments in intravesical therapy for non-muscle-invasive bladder cancer.

@nl

prefLabel

Developments in intravesical therapy for non-muscle-invasive bladder cancer.

@en

Developments in intravesical therapy for non-muscle-invasive bladder cancer.

@nl

P1433

Q37812604-BF93714D-40B9-4CC8-B483-B84E2A8F6D88

P1476

Q37812604-5A75FEA3-253D-4DBF-A44C-8D2E552830D8

P2093

Q37812604-596AFB94-71C9-4FF3-8DC1-937097A8906F

Q37812604-CCCE46D9-79D2-45AB-B74F-8DDB9DA777F6

P2860

Q37812604-032E55E0-FECB-4C5C-812C-9C9A59FFB150

Q37812604-04FF1908-3CE3-40D8-B98B-137DE1B0DBF8

Q37812604-0A9F1DBE-DA8E-465F-A9B9-4DC0027404DD

Q37812604-0B716BA4-5F2E-4707-A65A-8C2A8AEBE70B

Q37812604-0BAE454E-F72D-47A3-9E70-9EE8BAFA407B

Q37812604-110C48E8-EC4F-4A30-9F4E-2D153D8CF298

Q37812604-1241A4D8-DC53-4073-91BA-57C2A82EB65C

Q37812604-14009DA1-E33B-41ED-A23D-37ED5A03956C

Q37812604-15AD5DD9-A6C3-453B-AB72-419472B86E1E

Q37812604-17FE91F5-549C-49DB-A8B7-8D1BD5754C22

P304

Q37812604-6D5C4574-2C01-4C78-B353-B18908C63801

P31

Q37812604-D9903356-A87B-4475-857F-44EB2BC6AB0D

P356

Q37812604-8B6BE761-B38A-4E54-A440-B8B8D2D9244A

P433

Q37812604-6A6CFBAA-37C0-495B-A936-2294FC7EA33D

P478

Q37812604-4289D2A2-CE0A-4C4D-8880-DFA2F8F37064

P577

Q37812604-EF1A1CE8-0023-44C5-AC98-1325B6F6010F

P698

Q37812604-726DCC43-82E2-4AEA-92E4-5A80E1021310

P356

P1433

Expert Review of Anticancer Therapy

P1476

Developments in intravesical therapy for non-muscle-invasive bladder cancer.

@en

P2093

J Alfred Witjes

http://www.w3.org/2001/XMLSchema#string

Rianne J M Lammers

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2002

Photodynamic therapy with intravesical instillation of 5-aminolevulinic acid for patients with recurrent superficial bladder cancer: a single-center study.

Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trials.

An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer.

PDT combined with Intravesical BCG instillation would form an autovaccine for bladder cancer?

The accuracy of urinary cytology in daily practice.

Keyhole limpet hemocyanin (KLH): a biomedical review.

Long-term clinical outcomes of a phase I trial of intravesical docetaxel in the management of non-muscle-invasive bladder cancer refractory to standard intravesical therapy.

The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies.

Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high

P304

1903-1916

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERA.10.155

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21110757

http://www.w3.org/2001/XMLSchema#string